A mechanism for tamoxifen-mediated inhibition of acidification

被引:71
作者
Chen, Y
Schindler, M
Simon, SM
机构
[1] Rockefeller Univ, Lab Cellular Biophys, New York, NY 10021 USA
[2] Michigan State Univ, Dept Biochem, E Lansing, MI 48824 USA
关键词
D O I
10.1074/jbc.274.26.18364
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Tamoxifen has been reported to inhibit acidification of cytoplasmic organelles in mammalian cells. Here, the mechanism of this inhibition is investigated using in vitro assays on isolated organelles and liposomes. Tamoxifen inhibited ATP-dependent acidification in organelles from a variety of sources, including isolated microsomes from mammalian cells, vacuoles from Saccharomyces cerevisiae, and inverted membrane vesicles from Escherichia coli. Tamoxifen increased the ATPase activity of the vacuolar proton ATPase but decreased the membrane potential (V-m) generated by this proton pump, suggesting that tamoxifen may act by increasing proton permeability. In liposomes, tamoxifen increased the rate of pH dissipation. Studies comparing the effect of tamoxifen on pH gradients using different salt conditions and with other known ionophores suggest that tamoxifen affects transmembrane pH through two independent mechanisms. First, as a lipophilic weak base, it partitions into acidic vesicles, resulting in rapid neutralization. Second, it mediates coupled, electroneutral transport of proton or hydroxide with chloride. An understanding of the biochemical mechanism(s) for the effects of tamoxifen that are independent of the estrogen receptor could contribute to predicting side effects of tamoxifen and in designing screens to select for estrogen-receptor antagonists without these side effects.
引用
收藏
页码:18364 / 18373
页数:10
相关论文
共 49 条
[1]
Defective acidification in human breast tumor cells and implications for chemotherapy [J].
Altan, N ;
Chen, Y ;
Schindler, M ;
Simon, SM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (10) :1583-1598
[2]
Tamoxifen inhibits acidification in cells independent of the estrogen receptor [J].
Altan, N ;
Chen, Y ;
Schindler, M ;
Simon, SM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (08) :4432-4437
[3]
DEFECTIVE ACIDIFICATION OF INTRACELLULAR ORGANELLES IN CYSTIC-FIBROSIS [J].
BARASCH, J ;
KISS, B ;
PRINCE, A ;
SAIMAN, L ;
GRUENERT, D ;
ALAWQATI, Q .
NATURE, 1991, 352 (6330) :70-73
[4]
BERMAN E, 1995, LEUKEMIA, V9, P1631
[5]
BERMAN E, 1991, BLOOD, V77, P818
[6]
LONG-WAVELENGTH CHLORIDE-SENSITIVE FLUORESCENT INDICATORS [J].
BIWERSI, J ;
TULK, B ;
VERKMAN, AS .
ANALYTICAL BIOCHEMISTRY, 1994, 219 (01) :139-143
[7]
Cystic fibrosis transmembrane conductance regulator activation stimulates endosome fusion in vivo [J].
Biwersi, J ;
Emans, N ;
Verkman, AS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (22) :12484-12489
[8]
INHIBITION OF PROTEIN-KINASE-C BY CATIONIC AMPHIPHILES [J].
BOTTEGA, R ;
EPAND, RM .
BIOCHEMISTRY, 1992, 31 (37) :9025-9030
[9]
BAFILOMYCINS - A CLASS OF INHIBITORS OF MEMBRANE ATPASES FROM MICROORGANISMS, ANIMAL-CELLS, AND PLANT-CELLS [J].
BOWMAN, EJ ;
SIEBERS, A ;
ALTENDORF, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (21) :7972-7976
[10]
INTERACTION OF TAMOXIFEN WITH THE MULTIDRUG-RESISTANCE P-GLYCOPROTEIN [J].
CALLAGHAN, R ;
HIGGINS, CF .
BRITISH JOURNAL OF CANCER, 1995, 71 (02) :294-299